Sernova Company
Sernova develops regenerative medicine therapeutic technologies for treatment of chronic metabolic diseases.
Technology:
AgeTech Companies, Stem cell therapy, Stem cells therapy
Industry:
Healthcare, Public
Headquarters:
London, Ontario, Canada
Founded Date:
1998-08-19
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
1
Total Funding:
6200000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2018-07-16
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership